Article Versions Notes

Zafar A, Alruwaili NK, Imam SS, Alsaidan OA, Alkholifi FK, Alharbi KS, Mostafa EM, Alanazi AS, Gilani SJ, Musa A, et al. Formulation of Genistein-HP β Cyclodextrin-Poloxamer 188 Ternary Inclusion Complex: Solubility to Cytotoxicity Assessment. Pharmaceutics. 2021; 13(12):1997. https://doi.org/10.3390/pharmaceutics13121997

Zafar, Ameeduzzafar, Nabil K. Alruwaili, Syed Sarim Imam, Omar Awad Alsaidan, Faisal K. Alkholifi, Khalid Saad Alharbi, Ehab M. Mostafa, Abdullah S. Alanazi, Sadaf Jamal Gilani, Arafa Musa, and et al. 2021. "Formulation of Genistein-HP β Cyclodextrin-Poloxamer 188 Ternary Inclusion Complex: Solubility to Cytotoxicity Assessment" Pharmaceutics 13, no. 12: 1997. https://doi.org/10.3390/pharmaceutics13121997

Zafar, A., Alruwaili, N. K., Imam, S. S., Alsaidan, O. A., Alkholifi, F. K., Alharbi, K. S., Mostafa, E. M., Alanazi, A. S., Gilani, S. J., Musa, A., Alshehri, S., Rawaf, A., & Alquraini, A. (2021). Formulation of Genistein-HP β Cyclodextrin-Poloxamer 188 Ternary Inclusion Complex: Solubility to Cytotoxicity Assessment. Pharmaceutics, 13(12), 1997. https://doi.org/10.3390/pharmaceutics13121997